Chronic spontaneous urticaria (CSU) is responsible for 80% of all cases of chronic hives, but 90% of people never know what ...

Hives or urticaria are itchy bumps that appear on the skin. They can be big or small, vary in shape, and can appear anywhere ...

Jasper Therapeutics has reported complete responses in 10 of the 12 chronic hives patients who received the high dose of its ...

Celldex Therapeutics reported Wednesday that its experimental medicine for a condition that causes chronic hives reduced hive activity in patients, completely clearing it in some. However ...

KIT antibody has shown promise in a Phase 1b/2a test in people with certain irritable skin conditions, sending its shares ...

In spite of treatment advances, chronic urticaria continues to impair patients' health-related quality of life (HRQoL) and drive up direct and indirect healthcare costs. As early as 1997 ...

Harris has seasonal allergies and urticaria, which are chronic hives as a result of allergies. She typically manages her ...

CLDX stock has fallen 27.7% year-to-date, while the S&P 500 Index ($SPX) has risen 22.7%. Nonetheless, Wall Street expects the stock to skyrocket nearly 135% over the next 12 months, based on analysts ...

Jasper Therapeutics, a biotech looking to make stem cell transplants less taxing and to treat immune-mediated diseases, ...

AMSTERDAM — Patients with chronic spontaneous urticaria (CSU) experienced early and sustained improvements in symptom scores on treatment with barzolvolimab, during the 52-week follow-up of an ...

With positive results for patients with the chronic skin condition, Jasper Therapeutics’ briquilimab is looking to take on ...